1. Home
  2. SRTA vs LRMR Comparison

SRTA vs LRMR Comparison

Compare SRTA & LRMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

SRTA

Strata Critical Medical Inc.

HOLD

Current Price

$5.53

Market Cap

425.3M

Sector

N/A

ML Signal

HOLD

Logo Larimar Therapeutics Inc.

LRMR

Larimar Therapeutics Inc.

HOLD

Current Price

$3.98

Market Cap

455.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SRTA
LRMR
Founded
2014
N/A
Country
United States
United States
Employees
601
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
425.3M
455.8M
IPO Year
N/A
2014

Fundamental Metrics

Financial Performance
Metric
SRTA
LRMR
Price
$5.53
$3.98
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
6
Target Price
$7.81
$16.50
AVG Volume (30 Days)
741.8K
1.4M
Earning Date
05-06-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$39.27
N/A
Revenue Next Year
$8.52
$1,816.14
P/E Ratio
$9.88
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.85
$1.73
52 Week High
$6.02
$6.42

Technical Indicators

Market Signals
Indicator
SRTA
LRMR
Relative Strength Index (RSI) 69.70 37.18
Support Level $4.08 $3.87
Resistance Level $5.99 $4.29
Average True Range (ATR) 0.30 0.25
MACD 0.06 -0.06
Stochastic Oscillator 93.89 11.22

Price Performance

Historical Comparison
SRTA
LRMR

About SRTA Strata Critical Medical Inc.

Strata Critical Medical Inc is a time-critical logistics and medical services provider to the U.S. healthcare industry. The group operates one of the nation's air transport and surgical services networks for transplant hospitals and organ procurement organizations, offering an integrated 'One Call' solution for donor organ recovery. It includes two segments: Logistics segments which hold, Air Logistics, Ground Logistics and Organ Placement. The second segment is Clinical Segment which includes: Organ Recovery, Normothermic Regional Perfusion (NRP), and Preservation, and Other Clinical Segment which has Cardiac Care, and Other.

About LRMR Larimar Therapeutics Inc.

Larimar Therapeutics Inc is a clinical-stage biotechnology company focused on developing treatments for patients suffering from complex rare diseases using its novel cell-penetrating peptide (CPP) technology platform. Its lead product candidate, CTI-1601, is a subcutaneously administered, recombinant fusion protein intended to deliver human frataxin (FXN) an essential protein, to the mitochondria of patients with Friedreich's ataxia.

Share on Social Networks: